Increased incidence of late-onset inflammatory bowel disease and microscopic colitis after a Cryptosporidium hominis outbreak

References

• Büsch K, Ludvigsson JF, Ekström-Smedby K, et al. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther. 2014;39(1):57–68.
   PubMed Web of Science ®Google Scholar
• Mak WY, Zhao M, Ng SC, et al. The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol. 2020;35(3):380–389.
   PubMed Web of Science ®Google Scholar
• Vegh Z, Burisch J, Pedersen N, EpiCom-Group, et al. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis. 2014;8(11):1506–1515.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778.
   PubMed Web of Science ®Google Scholar
• Ng SC, Bernstein CN, Vatn MH, Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD), et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62(4):630–649.
   PubMed Web of Science ®Google Scholar
• Abegunde AT, Muhammad BH, Bhatti O, et al. Environmental risk factors for inflammatory bowel diseases: evidence based literature review. World J Gastroenterol. 2016;22(27):6296–6317.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Bernstein CN, Iliopoulos D, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39–49.
   PubMed Web of Science ®Google Scholar
• Sacco RE, Haynes JS, Harp JA, et al. Cryptosporidium parvum initiates inflammatory bowel disease in germfree T cell receptor-alpha-deficient mice. Am J Pathol. 1998;153(6):1717–1722.
   PubMed Web of Science ®Google Scholar
• Rogler G, Zeitz J, Biedermann L. The search for causative environmental factors in inflammatory bowel disease. Dig Dis. 2016;34(Suppl. 1):48–55.
   PubMed Web of Science ®Google Scholar
• Axelrad JE, Olén O, Askling J, et al. Gastrointestinal infection increases odds of inflammatory bowel disease in a nationwide case–control study. Clin Gastroenterol Hepatol. 2019;17(7):1311–1322.
   PubMed Web of Science ®Google Scholar
• Tong J, Zheng Q, Zhang C, et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(2):265–276.
   PubMed Web of Science ®Google Scholar
• Park T, Cave D, Marshall C. Microscopic colitis: a review of etiology, treatment and refractory disease. World J Gastroenterol. 2015;21(29):8804–8810.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Verhaegh B, Tontini GE, et al. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol. 2019;4(4):305–314.
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Dalager-Pedersen M, Nielsen H. High risk of microscopic colitis after Campylobacter concisus infection: population-based cohort study. Gut. 2020;69(11):1952–1958.
   PubMed Web of Science ®Google Scholar
• Khalili H, Axelrad JE, Roelstraete B, et al. Gastrointestinal infection and risk of microscopic colitis: a nationwide case–control study in Sweden. Gastroenterology. 2021;160(5):1599–1607.
   PubMed Web of Science ®Google Scholar
• Pogreba-Brown K, Austhof E, Armstrong A, et al. Chronic gastrointestinal and joint-related sequelae associated with common foodborne illnesses: a scoping review. Foodborne Pathog Dis. 2020;17(2):67–86.
   PubMed Web of Science ®Google Scholar
• Bouzid M, Hunter PR, Chalmers RM, et al. Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev. 2013;26(1):115–134.
   PubMed Web of Science ®Google Scholar
• Feng Y, Ryan UM, Xiao L. Genetic diversity and population structure of Cryptosporidium. Trends Parasitol. 2018;34(11):997–1011.
   PubMed Web of Science ®Google Scholar
• Checkley W, White AC Jr, Jaganath D, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium. Lancet Infect Dis. 2015;15(1):85–94.
   PubMed Web of Science ®Google Scholar
• Chalmers RM, Davies AP. Minireview: clinical cryptosporidiosis. Exp Parasitol. 2010;124(1):138–146.
   PubMed Web of Science ®Google Scholar
• Lilja M, Widerström M, Lindh J. Persisting post-infection symptoms 2 years after a large waterborne outbreak of Cryptosporidium hominis in northern Sweden. BMC Res Notes. 2018;11(1):625.
   PubMedGoogle Scholar
• Rehn M, Wallensten A, Widerström M, et al. Post-infection symptoms following two large waterborne outbreaks of Cryptosporidium hominis in northern Sweden, 2010–2011. BMC Public Health. 2015;15:529.
   PubMed Web of Science ®Google Scholar
• Hunter PR, Hughes S, Woodhouse S, et al. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis. 2004;39(4):504–510.
   PubMed Web of Science ®Google Scholar
• MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 1995;21(1):57–62.
   PubMed Web of Science ®Google Scholar
• Widerström M, Schönning C, Lilja M, et al. Large outbreak of Cryptosporidium hominis infection transmitted through the public water supply, Sweden. Emerg Infect Dis. 2014;20(4):581–589.
   PubMed Web of Science ®Google Scholar
• Adler S, Widerström M, Lindh J, et al. Symptoms and risk factors of Cryptosporidium hominis infection in children: data from a large waterborne outbreak in Sweden. Parasitol Res. 2017;116(10):2613–2618.
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. Population of jämtland county, 18 years and older, male/female, 2006–2019. [cited 2020 Oct 12]. Available from: https://www.statistikdatabasen.scb.se/pxweb/en/ssd/
   Google Scholar
• Ludvigsson JF, Andersson M, Bengtsson J, et al. Swedish inflammatory bowel disease register (SWIBREG) – a nationwide quality register. Scand J Gastroenterol. 2019;54(9):1089–1101.
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A.
   PubMed Web of Science ®Google Scholar
• Zhao M, Gönczi L, Lakatos PL, et al. The burden of inflammatory bowel disease in Europe in 2020. J Crohns Colitis. 2021;15(9):1573–1587.
   PubMed Web of Science ®Google Scholar
• Sjöberg D, Holmström T, Larsson M, et al. Incidence and natural history of ulcerative colitis in the Uppsala region of Sweden 2005–2009 – results from the IBD cohort of the Uppsala region (ICURE). J Crohns Colitis. 2013;7:351–357.
   PubMed Web of Science ®Google Scholar
• Sjöberg D, Holmström T, Larsson M, et al. Incidence and clinical course of Crohn's disease during the first year – results from the ibd cohort of the Uppsala region (icure) of Sweden 2005–2009. J Crohns Colitis. 2014;8(3):215–222.
   PubMed Web of Science ®Google Scholar
• Thörn M, Sjöberg D, Ekbom A, et al. Microscopic colitis in Uppsala health region, a population-based prospective study 2005–2009. Scand J Gastroenterol. 2013;48(7):825–830.
   PubMed Web of Science ®Google Scholar
• Bergman D, Clements MS, Khalili H, et al. A nationwide cohort study of the incidence of microscopic colitis in Sweden. Aliment Pharmacol Ther. 2019;49(11):1395–1400.
   PubMed Web of Science ®Google Scholar
• GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30.
   PubMed Web of Science ®Google Scholar
• Afzali A, Katz S. Inflammatory bowel disease in the baby to baby boomer: pediatric and elderly onset of IBD. Curr Treat Options Gastroenterol. 2018;16(3):289–305.
   PubMedGoogle Scholar
• Noverr MC, Huffnagle GB. The ‘microflora hypothesis’ of allergic diseases. Clin Exp Allergy. 2005;35(12):1511–1520.
   PubMed Web of Science ®Google Scholar
• Leong RW, Mitrev N, Ko Y. Hygiene hypothesis: is the evidence the same all over the world? Dig Dis. 2016;34(1–2):35–42.
   PubMed Web of Science ®Google Scholar
• Jess T, Simonsen J, Nielsen NM, et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut. 2011;60(3):318–324.
   PubMed Web of Science ®Google Scholar
• Axelrad JE, Cadwell KH, Colombel JF, et al. Systematic review: gastrointestinal infection and incident inflammatory bowel disease. Aliment Pharmacol Ther. 2020;51(12):1222–1232.
   PubMed Web of Science ®Google Scholar
• Di Re A, Liang Y, Gosselink MP, et al. Acute gastroenteritis in the etiology of inflammatory bowel disease: systematic review and meta-analysis. Crohn's Colitis 360. 2021;3(4):1–8.
   Google Scholar
• Porter CK, Welsh M, Riddle MS, et al. Epidemiology of inflammatory bowel disease among participants of the Millennium cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis. Aliment Pharmacol Ther. 2017;45(8):1115–1127.
   PubMed Web of Science ®Google Scholar
• Salih A, Widbom L, Hultdin J, et al. Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study. Scand J Gastroenterol. 2018;53(2):173–178.
   PubMed Web of Science ®Google Scholar
• Bonderup OK, Nielsen GL, Dall M, et al. Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case‐control study. Aliment Pharmacol Ther. 2018;48(6):618–625.
   PubMed Web of Science ®Google Scholar